Dominic Clarke, Ph.D.
Dominic Clarke is a recognized authority in the Cell and Gene Therapy (CGT) industry, bringing over 20 years of leadership and innovation to the field. As Vice President of Technical Operations at IntegriCell, Cryoport, he oversees technical development, MSAT, and operational services, driving forward the company’s mission to advance cell therapy manufacturing and delivery.
Throughout his career, Dominic has held key executive roles at leading biotech organizations including HemaCare (Charles River Laboratories), Charter Medical, and BioLife Solutions. His deep technical knowledge and strategic insight have consistently delivered operational excellence, enhanced visibility, and commercial growth.
Dominic earned his PhD in Cell and Molecular Biology from the State University of New York, with a specialization in cryopreservation and low-temperature biology, followed by postdoctoral research in developmental biology at Syracuse Upstate Medical University.
A long-standing contributor to the CGT community, Dominic has served for over 15 years on the International Society for Cell & Gene Therapy (ISCT) Process Development and Manufacturing Committee, where he currently leads as Chair—helping shape global standards and best practices in advanced therapy manufacturing.
He joined the Board of Trustees for Gulf Coast Blood in 2025.